Choong Ang Vaccine Laboratory Co. Ltd (072020.KQ) stock: key figures, P/E, revenue and dividend

Energy · Coal & Consumable Fuels · South Korea · ISIN KR7072020001

Price
8,790.00 KRW
Market cap
81.37 bn KRW
P/E (2025)
13.22
P/S (2025)
1.66
Dividend yield
2.28 %
Net margin
12.55 %
Return on equity (ROE)
5.84 %
Return on assets (ROA)
5.01 %

Choong Ang Vaccine Laboratory Co. Ltd financials

Fiscal year20242025
Revenue45.59 bn KRW49.07 bn KRW
Gross profit21.31 bn KRW23.89 bn KRW
Operating income5.76 bn KRW6.48 bn KRW
EBIT8.20 bn KRW6.77 bn KRW
Net income6.85 bn KRW6.16 bn KRW
Diluted EPS – continuing operations716.63 KRW665.11 KRW

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Choong Ang Vaccine Laboratory Co. Ltd

Choong Ang Vaccine Laboratory Co., Ltd. engages in the research, development, manufacturing, and sale of animal vaccines in South Korea, Asia, Africa, and the United States. It offers swine, poultry, cattle, canine, feline, wild boar, and raccoon vaccines under the SuiShot, PoulShot, BoviShot, CaniShot, and FeliShot brands. The company was founded in 1968 and is headquartered in Daejeon, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.